Serum PCSK9 levels in infants with deviant birth weight: a biomarker of the lipoprotein metabolism
{{output}}
Objective: Proprotein Convertase Subtilisin/Kexin-Type 9 (PCSK9), a modulator of low-density lipoprotein (LDL) cholesterol metabolism, has been reported to be a promising biomarker for evaluating lipoprotein metabolism; however, ... ...
